NCT00749229

Brief Summary

Some unstable traumatic vertebral fractures (types A3.2, A3.3, B1 et C1 according to MAGERL classification) may undergo unpredictable secondary displacement. Such fractures require a two session surgery with a first operation carried out immediately to achieve posterior fixation and a second surgery which is performed some days later to stabilize the anterior spine and restore stress resistance. Goal of the present study is to show that percutaneous Balloon Kyphoplasty is able to restore anterior spine strength and replace second session surgery.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
17

participants targeted

Target at below P25 for phase_4

Timeline
Completed

Started Dec 2007

Typical duration for phase_4

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2007

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

September 8, 2008

Completed
1 day until next milestone

First Posted

Study publicly available on registry

September 9, 2008

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2011

Completed
Last Updated

January 4, 2017

Status Verified

December 1, 2014

Enrollment Period

3.2 years

First QC Date

September 8, 2008

Last Update Submit

January 3, 2017

Conditions

Keywords

Traumatic vertebral fractureBalloon Kyphoplastytype A3.2, or A3.3 or B1 or C1 in the MAGERL CLASSIFICATION

Outcome Measures

Primary Outcomes (1)

  • Loss of less than 10 degrees in spine kyphosis angle at one year follow-up after surgery compared to postoperative measurements

    1 year

Secondary Outcomes (10)

  • Pain evaluation using a visual analogic scale

    J-20 to J-7 - J6 - J45 - J90 - J180 - J360

  • EIFEL questionnaire for back pain evaluation

    J-20 to J-7 - J6 - J45 - J90 - J180 - J360

  • Quality of life evaluation (SF 12).

    J-20 to J-7 - J6 - J45 - J90 - J180 - J360

  • Analgesics intake according to the WHO classification (Classes 1, 2 and 3).

    J-20 to J-7 - J6 - J45 - J90 - J180 - J360

  • Regional spine Kyphosis angle and global thoracic and lumbar Kyphosis angle.

    J-20 to J-7 - J6 - J45 - J90 - J180 - J360

  • +5 more secondary outcomes

Study Arms (1)

1

OTHER

Balloon kyphoplasty

Device: balloon kyphoplasty

Interventions

During the same surgery or some days later on, percutaneous Balloon kyphoplasty of the fractured vertebral body (ies) using polymethylmetacrylate cement injection through a posterior transpedicular approach will be carried out in replacement of anterior spine surgery to restore vertebral body strength

1

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Preliminary clinical examination (the anaesthesist must have provided his approval for the surgical procedure)
  • Patient must have signed the consent form
  • Male or female patient aged 18 or over
  • One or two traumatic vertebral fractures located between T11 and L5 and type A3.2, A3.3, B1 or C1 in the MAGERL classification, and with a regional kyphotic angle \> 15° and treated by osteosynthesis through a posterior surgical approach with or without spinal decompression
  • Fracture with or without neurological difficulties
  • Non tumoral origin: Confirmed by biopsy at the same time of the Balloon Kyphoplasty procedure.

You may not qualify if:

  • Non- traumatic, malignant or osteoporotic vertebral fractures
  • History of surgical or percutaneous spine treatment except simple discectomy at a single or multiple vertebral levels with no residual pain.
  • Known allergy to a contrast media or to one of the cement components used for kyphoplasty.
  • More than two recent vertebral fractures
  • Current infection
  • Impossibility to perform the percutaneous approach of the vertebra to treat.
  • Reduction by more than 50% of the anteroposterior width of the bony spinal canal due to the vertebral fracture to treat.
  • Vertebral fracture with loss of 90%or more of the vertebral body height
  • Patient presenting a non correctable spontaneous or therapeutic coagulation disorder.
  • Evolutive cardiac disease nonreactive to medical treatment
  • Non compliant patient: Impossibility to participate to the study and to be followed up for 1 year.
  • Pregnant or breast feeding women
  • Patient not affiliated to social security

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Service de Radiologie, Hôpital Lariboisière

Paris, 75010, France

Location

MeSH Terms

Interventions

Kyphoplasty

Intervention Hierarchy (Ancestors)

VertebroplastyCementoplastyOrthopedic ProceduresTherapeuticsSurgical Procedures, Operative

Study Officials

  • Jean-Denis LAREDO, M.D.,PR.

    AP/HP Assistance Publique-Hôpitaux de Paris

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 8, 2008

First Posted

September 9, 2008

Study Start

December 1, 2007

Primary Completion

March 1, 2011

Study Completion

March 1, 2011

Last Updated

January 4, 2017

Record last verified: 2014-12

Locations